Live webinar | Monday 21 December 2026 | 17:00–18:00 CET

Join this live ParadigMS webinar for an expert-led discussion on new and emerging therapies in myasthenia gravis, with a focus on their relevance for clinical practice.

During this one-hour session, Andrew Chan, Maura Pugliatti and Celia Oreja-Guevara will review current developments and discuss how advances in treatment may influence therapeutic decision-making.

The session will bring together leading experts to discuss current clinical considerations and provide practical insights relevant to neurologists and healthcare professionals involved in MS care.

Register to join the live webinar and hear perspectives from leading neurology experts.

Key Highlights

The session will provide an expert overview of the changing treatment landscape in myasthenia gravis and its implications for clinical practice. Participants will have the opportunity to:

• Explore recent developments in therapies for myasthenia gravis.
• Review the evolving therapeutic landscape.
• Consider the clinical relevance of new treatment options.
• Hear expert perspectives on treatment decision-making.
• Join the discussion during the live session.

More information & Learning Objectives to come soon

Register

This session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions! 

Language

The session will be held in English with translated auto-captions into many languages (offered by Zoom platform).

Who should attend?

• Neurologists and paediatric neurologists with an interest in Multiple Sclerosis
• MS specialists and neurologists in training
• Nurses and other healthcare professionals involved in MS care
• Healthcare professionals involved in the diagnosis or management of paediatric demyelinating disorders

Questions and comments

Should you have specific questions, you would like to see discussed, please share them with learning@paradigms.foundation now, so the speakers could relate to them in their presentations. 

You will also have the opportunity to ask questions in person and participate in discussion during the webinar and the Q&A session.

Technology used

The webinar takes place via Zoom, you will receive connection details upon registration.

Date and time

Date: Monday 21 December 2026
Time: 17:00-18:00 CET
Format: Live online webinar
Duration: 60 minutes

Speakers

Find out more about the speakers:

Celia Oreja-Guevara

Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid

Andrew Chan

Head of the Medical Division Neuro at the Bern University Hospital

Maura Pugliatti

Professor of Neurology at the University of Ferrara

Funding

This webinar is funded with ParadigMS own funds. No other sponsors have been invited to support this webinar.